Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

700 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM).
Mueller RB, Reshiti N, Kaegi T, Finckh A, Haile SR, Schulze-Koops H, Schiff M, Spaeth M, von Kempis J; SCQM physicians. Mueller RB, et al. Among authors: schiff m. Clin Rheumatol. 2017 Jan;36(1):59-66. doi: 10.1007/s10067-016-3468-6. Epub 2016 Nov 12. Clin Rheumatol. 2017. PMID: 27838788 Free article.
Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort.
Mueller RB, Kaegi T, Haile SR, Schulze-Koops H, Schiff M, von Kempis J. Mueller RB, et al. Among authors: schiff m. RMD Open. 2018 Jun 6;4(1):e000673. doi: 10.1136/rmdopen-2018-000673. eCollection 2018. RMD Open. 2018. PMID: 29955385 Free PMC article.
Analysis of patients with rheumatoid arthritis and higher radiographic progression: association of very high radiographic progression but not of intermediately high with worsening of patient-related outcomes.
Thalmann R, von Kempis J, Zgraggen A, Graf N, Schiff M, Sokka T, Dietrich T, Schulze-Koops H, Mueller RB. Thalmann R, et al. Among authors: schiff m. Clin Exp Rheumatol. 2022 Mar;40(3):589-595. doi: 10.55563/clinexprheumatol/jpysud. Epub 2021 May 5. Clin Exp Rheumatol. 2022. PMID: 34001300
Rheumatoid arthritis secondary non-responders to TNF can attain an efficacious and safe response by switching to certolizumab pegol: a phase IV, randomised, multicentre, double-blind, 12-week study, followed by a 12-week open-label phase.
Schiff MH, von Kempis J, Goldblum R, Tesser JR, Mueller RB. Schiff MH, et al. Ann Rheum Dis. 2014 Dec;73(12):2174-7. doi: 10.1136/annrheumdis-2014-205325. Epub 2014 Jun 27. Ann Rheum Dis. 2014. PMID: 24972708 Clinical Trial.
700 results